pharmaceuticals-and-healthcare

United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2017


Published On : Jun 2017

Category : Pharmaceutical

No. of Pages : 98 pages

  • $3800
  • $7600

Please click below to avail discount on this report

In this report, the United States Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs in these regions, from 2012 to 2022 (forecast).

United States Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers/players, with Chemotherapy-Induced Nausea and Vomiting Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs for each application, including
Serotonin Receptor Antagonists
NK1 Receptor Antagonists

In the recent times, the global market for United states chemotherapy induced nausea and vomiting drugs market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of United states chemotherapy induced nausea and vomiting drugs market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the United states chemotherapy induced nausea and vomiting drugs market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the United states chemotherapy induced nausea and vomiting drugs market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of United states chemotherapy induced nausea and vomiting drugs market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for United states chemotherapy induced nausea and vomiting drugs market report 2017, including the definition, classification, and industry chain structure of United states chemotherapy induced nausea and vomiting drugs market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the United states chemotherapy induced nausea and vomiting drugs market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for United states chemotherapy induced nausea and vomiting drugs market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning United states chemotherapy induced nausea and vomiting drugs market report 2017, implemented in each of the geographical segments. The predominant applications of the United states chemotherapy induced nausea and vomiting drugs market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for United states chemotherapy induced nausea and vomiting drugs market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the United states chemotherapy induced nausea and vomiting drugs market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Existing Drugs Product Picture
Figure Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure Aloxi (Palonosetron) Product Picture
Figure Emend (Aprepitant) Product Picture
Figure Kytril Generic (Granisetron) Product Picture
Figure Zofran Generic (Ondansetron) Product Picture
Figure Pipeline Drugs Product Picture
Figure SUSTOL (Granisetron Injection extended release) Product Picture
Figure Rolapitant Product Picture
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2016
Figure Serotonin Receptor Antagonists Examples
Figure NK1 Receptor Antagonists Examples
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers
Table United States Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 3 Players/Suppliers
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Chemotherapy-Induced Nausea and Vomiting Drugs Product Category
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Region (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2012-2017)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Type (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2012-2017)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2016
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Tesaro, Inc. Basic Information List
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Helsinn Group Basic Information List
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Heron Therapeutics, Inc. Basic Information List
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Dr. Reddy's Laboratories Ltd. Basic Information List
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Acacia Pharma Basic Information List
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Sun Pharmaceutical Industry Ltd. Basic Information List
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Otsuka Holdings Co., Ltd. Basic Information List
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2012-2017)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Players/Suppliers in 2016
Table Major Buyers of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Distributors/Traders List
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top